BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 5368636)

  • 1. [Comparison of the adverse effects of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Rózewska M
    Gruzlica; 1969 Dec; 37(12):1103-6. PubMed ID: 5368636
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects and toxicity of ethionamide and prothionamide.
    Tala E; Tevola K
    Ann Clin Res; 1969 May; 1(1):32-5. PubMed ID: 5350768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 5. [2 cases of agranulocytosis during therapy with ethionamide and ethoxyd in patients with pulmonary tuberculosis].
    Kurenkova VV
    Probl Tuberk; 1967; 45(4):82-3. PubMed ID: 5605430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trevintix in the treatment of tuberculous patients (tolerance evaluation)].
    Pregowski W; Zagórecka A
    Gruzlica; 1968; 37(1):39-42. PubMed ID: 5720036
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on the ketogenic effect of certain antitubercular drugs in patients with diabetes and pulmonary tuberculosis].
    Onisk J
    Wiad Lek; 1968 May; 21(9):743-5. PubMed ID: 4875998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aluminum and magnesium pentasilicates associated with pectin and sorbitol in gastrointestinal disorders observed in children during treatment by tuberculostatics].
    Gerbeaux J; Baculard A; Hanoteau J
    Actual Hepatogastroenterol (Paris); 1968; 4(1):B23-4. PubMed ID: 5721702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Manifestations of a rheumatic type caused by antituberculosis chemotherapy].
    Anastasatu C; Kauffmann S; Iancovici O
    Med Interna (Bucur); 1969 May; 21(5):557-60. PubMed ID: 5307329
    [No Abstract]   [Full Text] [Related]  

  • 15. Capreomycin-ethionamide as a retreatment regimen for pulmonary tuberculosis.
    Schless JM; Allison RF; Inglis RM; Topperman S; Trapp E
    Ann N Y Acad Sci; 1966 Apr; 135(2):1085-97. PubMed ID: 5328002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side-effects of tuberculostatics on the macroorganism].
    Kürti V
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):271-3. PubMed ID: 5755197
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of SIADH caused by ethionamide in a patient with pulmonary tuberculosis].
    Nakashita T; Motojima S
    Kekkaku; 2006 Dec; 81(12):731-5. PubMed ID: 17240918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.